Masahiko Azuma

CXCL9 and 11 in patients with pulmonary sarcoidosis: a role of alveolar macrophages

Yasuhiko Nishioka, Kenji Manabe, J Kishi et al. · Clinical & Experimental Immunology · 2007 · 65 citations · Full text

Life Sciences, Immunology, Pathology +16

Antiallergic and Anti-Inflammatory Effects of a Novel IκB Kinase β Inhibitor, IMD-0354, in a Mouse Model of Allergic Inflammation

Akemi Sugita, Hirohisa Ogawa, Masahiko Azuma et al. · International Archives of Allergy and Immunology · 2008 · 59 citations

Life Sciences, Immunology, Pharmacology +15

Upregulatory Effects of Interleukin-4 and Interleukin-13 but Not Interleukin-10 on Granulocyte/Macrophage Colony-Stimulating Factor Production by Human Bronchial Epithelial Cells

Yoichi Nakamura, Masahiko Azuma, Yuri Okano et al. · American Journal of Respiratory Cell and Molecular Biology · 1996 · 47 citations

Life Sciences, Immunology, Pathology +14

IκB kinase β inhibitor IMD-0354 suppresses airway remodelling in a Dermatophagoides pteronyssinus-sensitized mouse model of chronic asthma

Hirohisa Ogawa, Masahiko Azuma, Susumu Muto et al. · Clinical & Experimental Allergy · 2010 · 46 citations

Life Sciences, Immunology, Pharmacology +17

A report of two bronchioloalveolar carcinoma cases which were rapidly improved by treatment with the epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 (“Iressa”¹

Seiji Yano, Takanori Kanematsu, Toyokazu Miki et al. · Cancer Science · 2003 · 45 citations · Full text

Medicine, Oncology, Pharmacology +13